Skip to main content
IN

Intellia Therapeutics

Cambridge, United States
Last funding
$400.0M
Post-IPO DebtSep 2026

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

About Intellia Therapeutics

How much funding has Intellia Therapeutics raised?

Intellia Therapeutics has raised $400.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in September 2026.

Who are Intellia Therapeutics's investors?

Intellia Therapeutics's investors include Novartis, OrbiMed, Foresite Capital, Fidelity, EcoR1 Capital.

Where is Intellia Therapeutics headquartered?

Intellia Therapeutics is headquartered in Cambridge, United States.

What does Intellia Therapeutics do?

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

What stage is Intellia Therapeutics at?

Intellia Therapeutics is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Intellia Therapeutics — Funding & Investors." VCBacked, September 4, 2026, https://www.vcbacked.co/company/intellia-therapeutics. Accessed November 15, 2026.
APA
VCBacked. (2026). Intellia Therapeutics — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/intellia-therapeutics
Wikipedia (cite web)
{{cite web |title=Intellia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/intellia-therapeutics |website=VCBacked |access-date=November 15, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Intellia Therapeutics? Request a listing update

Founder contacts
m***@intelliatx.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →